$59.68
0.000.00%
Pre-Market: 4:00 PM EDT
Comments
Loading...
Conmed Stock Guidance | NYSE:CNMD | Benzinga
Conmed issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/05/2025 | CNMD | Conmed | FY | 2025 | $4.25 | $4.40 | $4.74 | $1.34B | $1.37B | $1.40B | Get Alert |
| 10/30/2024 | CNMD | Conmed | FY | 2024 | $4.00 | $4.05 | $3.99 | $1.30B | $1.30B | $1.31B | Get Alert |
| 10/04/2024 | CNMD | Conmed | Q3 | 2024 | $0.98 | $1.00 | $0.99 | $315.00M | $318.00M | $318.67M | Get Alert |
| 07/31/2024 | CNMD | Conmed | FY | 2024 | $3.95 | $4.02 | $4.29 | $1.30B | $1.31B | $1.33B | Get Alert |
| 04/24/2024 | CNMD | Conmed | FY | 2024 | $4.25 | $4.35 | $4.33 | $1.33B | $1.35B | $1.35B | Get Alert |
| 01/31/2024 | CNMD | Conmed | FY | 2024 | $4.30 | $4.40 | $4.40 | $1.34B | $1.36B | $1.36B | Get Alert |
| 10/25/2023 | CNMD | Conmed | FY | 2023 | $3.45 | $3.55 | $3.48 | $1.24B | $1.26B | $1.25B | Get Alert |
| 07/26/2023 | CNMD | Conmed | FY | 2023 | $3.40 | $3.55 | $3.42 | $1.23B | $1.26B | $1.23B | Get Alert |
| 04/26/2023 | CNMD | Conmed | Q2 | 2023 | $0.77 | $0.82 | $0.79 | $300.00M | $310.00M | $301.46M | Get Alert |
| 04/26/2023 | CNMD | Conmed | FY | 2023 | $3.30 | $3.50 | $3.32 | $1.21B | $1.25B | $1.19B | Get Alert |
| 02/02/2023 | CNMD | Conmed | Q1 | 2023 | $0.58 | $0.63 | $0.61 | $262.00M | $272.00M | $268.73M | Get Alert |
| 02/02/2023 | CNMD | Conmed | FY | 2023 | $3.20 | $3.45 | $3.37 | $1.17B | $1.22B | $1.21B | Get Alert |
| 11/15/2022 | CNMD | Conmed | FY | 2023 | $3.20 | $3.50 | $3.39 | $1.17B | $1.23B | $1.21B | Get Alert |
| 10/26/2022 | CNMD | Conmed | FY | 2022 | $3.21 | $3.28 | $3.28 | $1.10B | $1.11B | $1.11B | Get Alert |
| 10/26/2022 | CNMD | Conmed | Q4 | 2022 | $0.98 | $1.05 | $1.06 | $305.00M | $320.00M | $313.65M | Get Alert |
| 07/27/2022 | CNMD | Conmed | Q3 | 2022 | $0.78 | $0.84 | $0.92 | $275.00M | $290.00M | $284.96M | Get Alert |
| 07/27/2022 | CNMD | Conmed | FY | 2022 | $3.40 | $3.55 | $3.50 | $1.09B | $1.14B | $1.12B | Get Alert |
| 05/04/2022 | CNMD | Conmed | FY | 2022 | $3.50 | $3.65 | $3.69 | $1.10B | $1.15B | $1.09B | Get Alert |
| 01/26/2022 | CNMD | Conmed | FY | 2022 | $3.60 | $3.85 | $3.74 | $1.07B | $1.13B | $1.11B | Get Alert |
| 10/27/2021 | CNMD | Conmed | FY | 2021 | $3.18 | $3.23 | $3.19 | $1.01B | $1.01B | $1.03B | Get Alert |
| 07/28/2021 | CNMD | Conmed | FY | 2021 | $3.15 | $3.25 | $3.15 | $1.01B | $1.03B | $1.02B | Get Alert |
| 04/28/2021 | CNMD | Conmed | FY | 2021 | $3.05 | $3.20 | $2.94 | $1.00B | $1.03B | $996.57M | Get Alert |
| 01/27/2021 | CNMD | Conmed | Q1 | 2021 | $0.42 | $0.45 | $0.59 | $210.00M | $225.00M | $235.55M | Get Alert |
| 01/27/2021 | CNMD | Conmed | FY | 2021 | $2.85 | $3.05 | $3.02 | $975.00M | $1.02B | $1.02B | Get Alert |
FAQ
What is the most recent guidance for Conmed (CNMD)?
The most recent guidance for Conmed (CNMD) was reported on February 5, 2025 for the full year 2025. The company provided earnings per share guidance in the range of $4.25 to $4.40, compared to the estimated EPS of $4.74. Additionally, Conmed forecasted revenue between $1.34B and $1.37B for the quarter.
Browse guidance and forecast on all stocks.